PHARMACOKINETIC INTERACTION BETWEEN A NOVEL ANGIOTENSIN II RECEPTOR BLOCKER, FIMASARTAN, AND HYDROCHLOROTHIAZIDE IN HEALTHY VOLUNTEERS.

被引：0
|
作者：
Kim, J. W. [1 ,2 ]
Kim, B. R. [1 ,2 ]
Shim, J. H. [1 ,2 ]
Yoon, S. H. [1 ,2 ]
Cho, J. Y. [1 ,2 ]
Shin, S. G. [1 ,2 ]
Yu, K. S. [1 ,2 ]
Jang, I. J. [1 ,2 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Clin Pharmacol & Therapeut, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Seoul 110744, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2010年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S53 / S54
页数：2
相关论文
共 50 条
  • [1] ASSESSMENT OF THE PHARMACOKINETIC INTERACTION BETWEEN FIMASARTAN AND LINAGLIPTIN IN HEALTHY VOLUNTEERS.
    Seong, S.
    Kang, W.
    Ohk, B.
    Kim, B.
    Gwon, M. -R.
    Cho, S.
    Lee, H.
    Yoon, Y. -R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S70 - S70
  • [2] Pharmacokinetic Interaction of Fimasartan, a New Angiotensin II Receptor Antagonist, With Amlodipine in Healthy Volunteers
    Yi, SoJeong
    Kim, Tae-Eun
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Shin, Sang-Goo
    Jang, In-Jin
    Yu, Kyung-Sang
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 57 (06) : 682 - 689
  • [3] EFFECTS OF FIMASARTAN, A NOVEL ANGIOTENSIN II RECEPTOR BLOCKER, ON THE PHARMACOKINETICS OF ATORVASTATIN AND ITS METABOLITES IN HEALTHY VOLUNTEERS
    Kim, S.
    Shin, K.
    Lee, S.
    Yoon, S.
    Cho, J.
    Jang, I.
    Yu, K.
    Shin, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S29 - S30
  • [4] PHARMACOKINETIC DRUG INTERACTION BETWEEN TELMISARTAN/AMLODIPINE AND HYDROCHLOROTHIAZIDE IN HEALTHY MALE VOLUNTEERS.
    Kim, M. -G.
    Lee, S.
    Kim, Y.
    Kim, S. -Y.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S73 - S74
  • [5] PHARMACOKINETIC INTERACTION BETWEEN FIMASARTAN AND AMLODIPINE IN HEALTHY VOLUNTEERS
    Cha, Y.
    Yi, S.
    Gu, N.
    Yoon, S.
    Cho, J.
    Yu, K.
    Shin, S.
    Jang, I.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S91 - S91
  • [6] Pharmacokinetic interaction of the oral renin inhibitor aliskiren with hydrochlorothiazide in healthy volunteers.
    Dieterich, H
    Kemp, C
    Vaidyanathan, S
    Yeh, C
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P12 - P12
  • [7] Assessment of the pharmacokinetic interaction between fimasartan and linagliptin in healthy volunteers
    Seong, S. J.
    Kang, W. Y.
    Ohk, B.
    Kim, B. K.
    Gwon, M. -R.
    Cho, S.
    Lee, H. W.
    Yoon, Y. -R.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S41 - S41
  • [8] A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
    Kang, Woo Youl
    Lee, Hae Won
    Gwon, Mi-Ri
    Cho, Seungil
    Shim, Wang-Seob
    Lee, Kyung-Tae
    Yang, Dong Heon
    Seong, Sook Jin
    Yoon, Young-Ran
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2101 - 2111
  • [9] Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
    Choi, Yewon
    Lee, SeungHwan
    Jang, In-Jin
    Yu, Kyung-Sang
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 2301 - 2309
  • [10] PHARMACOKINETIC INTERACTION BETWEEN ROSUVASTATIN AND FENOFIBRATE IN HEALTHY VOLUNTEERS.
    Yi, S.
    Kim, M.
    Han, S.
    Park, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S62 - S62
12345